Human Gene ELOVL4 (uc003pja.4)
  Description: Homo sapiens ELOVL fatty acid elongase 4 (ELOVL4), mRNA.
RefSeq Summary (NM_022726): This gene encodes a membrane-bound protein which is a member of the ELO family, proteins which participate in the biosynthesis of fatty acids. Consistent with the expression of the encoded protein in photoreceptor cells of the retina, mutations and small deletions in this gene are associated with Stargardt-like macular dystrophy (STGD3) and autosomal dominant Stargardt-like macular dystrophy (ADMD), also referred to as autosomal dominant atrophic macular degeneration. [provided by RefSeq, Jul 2008].
Transcript (Including UTRs)
   Position: hg19 chr6:80,624,529-80,657,315 Size: 32,787 Total Exon Count: 6 Strand: -
Coding Region
   Position: hg19 chr6:80,626,325-80,656,996 Size: 30,672 Coding Exon Count: 6 

Page IndexSequence and LinksUniProtKB CommentsPrimersGenetic AssociationsMalaCards
CTDGene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein Structure
Other SpeciesGO AnnotationsmRNA DescriptionsPathwaysOther NamesGeneReviews
Model InformationMethods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr6:80,624,529-80,657,315)mRNA (may differ from genome)Protein (314 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
GeneNetworkH-INVHGNCHPRDLynxMalacards
MGIneXtProtOMIMPubMedReactomeTreefam
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: ELOV4_HUMAN
DESCRIPTION: RecName: Full=Elongation of very long chain fatty acids protein 4; EC=2.3.1.199; AltName: Full=3-keto acyl-CoA synthase ELOVL4; AltName: Full=ELOVL fatty acid elongase 4; Short=ELOVL FA elongase 4; AltName: Full=Very-long-chain 3-oxoacyl-CoA synthase 4;
FUNCTION: Condensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Elongates C24:0 and C26:0 acyl-CoAs. Seems to represent a photoreceptor- specific component of the fatty acid elongation system residing on the endoplasmic reticulum. May be implicated in docosahexaenoic acid (DHA) biosynthesis, which requires dietary consumption of the essential alpha-linolenic acid and a subsequent series of three elongation steps. May play a critical role in early brain and skin development.
CATALYTIC ACTIVITY: A very-long-chain acyl-CoA + malonyl-CoA = CoA + a very-long-chain 3-oxoacyl-CoA + CO(2).
SUBUNIT: Oligomer.
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass membrane protein.
TISSUE SPECIFICITY: Expressed in the retina and at much lower level in the brain. Ubiquitous, highest expression in thymus, followed by testis, small intestine, ovary, and prostate. Little or no expression in heart, lung, liver, or leukocates.
DOMAIN: The di-lysine motif may confer endoplasmic reticulum localization (By similarity).
DISEASE: Defects in ELOVL4 are the cause of Stargardt disease type 3 (STGD3) [MIM:600110]. STGD is one of the most frequent causes of macular degeneration in childhood. It is characterized by macular dystrophy with juvenile-onset, rapidly progressive course, alterations of the peripheral retina, and subretinal deposition of lipofuscin-like material. STGD3 inheritance is autosomal dominant.
DISEASE: Defects in ELOVL4 are the cause of ichthyosis, spastic quadriplegia, and mental retardation (ISQMR) [MIM:614457]. A severe autosomal recessive disorder characterized by ichthyosis apparent from birth, profound psychomotor retardation with essentially no development, spastic quadriplegia, and seizures.
SIMILARITY: Belongs to the ELO family.
WEB RESOURCE: Name=Mutations of the ELOVL4 gene; Note=Retina International's Scientific Newsletter; URL="http://www.retina-international.org/files/sci-news/elovlmut.htm";
WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/ELOVL4";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): ELOVL4
CDC HuGE Published Literature: ELOVL4

-  MalaCards Disease Associations
  MalaCards Gene Search: ELOVL4
Diseases sorted by gene-association score: spinocerebellar ataxia 34* (1596), ichthyosis, spastic quadriplegia, and mental retardation* (1269), stargardt disease 3* (1040), stargardt disease* (223), ichthyosis, spastic qudraplegia and mental retardation* (100), spastic quadriplegia (34), quadriplegia (19), stargardt macular degeneration (10), stargardt disease 1 (10), doyne honeycomb degeneration of retina (8), retinitis pigmentosa 25 (7), degeneration of macula and posterior pole (6), macular degeneration, age-related, 1 (5), erythrokeratodermia variabilis et progressiva 1 (5), retinal disease (3), retinitis pigmentosa (2), leber congenital amaurosis (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 28.69 RPKM in Skin - Sun Exposed (Lower leg)
Total median expression: 204.59 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -146.00319-0.458 Picture PostScript Text
3' UTR -425.711796-0.237 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR002076 - GNS1_SUR4

Pfam Domains:
PF01151 - GNS1/SUR4 family

ModBase Predicted Comparative 3D Structure on Q9GZR5
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologGenome BrowserGenome BrowserNo orthologNo ortholog
Gene Details  Gene Details  
Gene Sorter  Gene Sorter  
  EnsemblFlyBase  
  Protein SequenceProtein Sequence  
  AlignmentAlignment  

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0005515 protein binding
GO:0008020 G-protein coupled photoreceptor activity
GO:0009922 fatty acid elongase activity
GO:0016740 transferase activity
GO:0102336 3-oxo-arachidoyl-CoA synthase activity
GO:0102337 3-oxo-cerotoyl-CoA synthase activity
GO:0102338 3-oxo-lignoceronyl-CoA synthase activity

Biological Process:
GO:0006629 lipid metabolic process
GO:0006631 fatty acid metabolic process
GO:0006633 fatty acid biosynthetic process
GO:0009584 detection of visible light
GO:0019367 fatty acid elongation, saturated fatty acid
GO:0030148 sphingolipid biosynthetic process
GO:0034625 fatty acid elongation, monounsaturated fatty acid
GO:0034626 fatty acid elongation, polyunsaturated fatty acid
GO:0042761 very long-chain fatty acid biosynthetic process

Cellular Component:
GO:0005783 endoplasmic reticulum
GO:0005789 endoplasmic reticulum membrane
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0030176 integral component of endoplasmic reticulum membrane


-  Descriptions from all associated GenBank mRNAs
  AJ420478 - Homo sapiens mRNA full length insert cDNA clone EUROIMAGE 1625104.
AY037298 - Homo sapiens elongation of very long chain fatty acids protein (ELOVL4) mRNA, complete cds.
AF277094 - Homo sapiens ELOVL4 mRNA, complete cds.
BC038506 - Homo sapiens elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4, mRNA (cDNA clone MGC:33699 IMAGE:5263012), complete cds.
JD298726 - Sequence 279750 from Patent EP1572962.
JD315798 - Sequence 296822 from Patent EP1572962.
JD290484 - Sequence 271508 from Patent EP1572962.
AK055277 - Homo sapiens cDNA FLJ30715 fis, clone FCBBF2001538, weakly similar to Homo sapiens long chain polyunsaturated fatty acid elongation enzyme (HELO1) mRNA.
JD431182 - Sequence 412206 from Patent EP1572962.
JD486866 - Sequence 467890 from Patent EP1572962.
JD562511 - Sequence 543535 from Patent EP1572962.
JD528409 - Sequence 509433 from Patent EP1572962.
JD271865 - Sequence 252889 from Patent EP1572962.
JD309368 - Sequence 290392 from Patent EP1572962.
JD436616 - Sequence 417640 from Patent EP1572962.
JD433773 - Sequence 414797 from Patent EP1572962.
JD082257 - Sequence 63281 from Patent EP1572962.
JD324937 - Sequence 305961 from Patent EP1572962.
AK310625 - Homo sapiens cDNA, FLJ17667.
AK312511 - Homo sapiens cDNA, FLJ92876, Homo sapiens elongation of very long chain fatty acids (FEN1/Elo2,SUR4/Elo3, yeast)-like 4 (ELOVL4), mRNA.
DQ891229 - Synthetic construct clone IMAGE:100003859; FLH170351.01X; RZPDo839E0698D elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 (ELOVL4) gene, encodes complete protein.
HQ447854 - Synthetic construct Homo sapiens clone IMAGE:100071198; CCSB001976_02 elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 (ELOVL4) gene, encodes complete protein.
CU691582 - Synthetic construct Homo sapiens gateway clone IMAGE:100018854 5' read ELOVL4 mRNA.
JD152803 - Sequence 133827 from Patent EP1572962.
JD129097 - Sequence 110121 from Patent EP1572962.
JD520496 - Sequence 501520 from Patent EP1572962.
JD406518 - Sequence 387542 from Patent EP1572962.
JD417307 - Sequence 398331 from Patent EP1572962.
DQ426871 - Homo sapiens elongation of very long chain fatty acids-like protein 4 (ELOVL4) mRNA, 5' UTR.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein Q9GZR5 (Reactome details) participates in the following event(s):

R-HSA-548830 ELOVL1,4 elongate TCS-CoA and Mal-CoA to 3OHC-CoA
R-HSA-75876 Synthesis of very long-chain fatty acyl-CoAs
R-HSA-75105 Fatty acyl-CoA biosynthesis
R-HSA-8978868 Fatty acid metabolism
R-HSA-556833 Metabolism of lipids
R-HSA-1430728 Metabolism

-  Other Names for This Gene
  Alternate Gene Symbols: B2R6B5, ELOV4_HUMAN, NM_022726, NP_073563, Q5TCS2, Q86YJ1, Q9GZR5, Q9H139
UCSC ID: uc003pja.4
RefSeq Accession: NM_022726
Protein: Q9GZR5 (aka ELOV4_HUMAN or ELO4_HUMAN)
CCDS: CCDS4992.1

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene ELOVL4:
ataxias (Hereditary Ataxia Overview)

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_022726.3
exon count: 6CDS single in 3' UTR: no RNA size: 3085
ORF size: 945CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 2090.00frame shift in genome: no % Coverage: 99.19
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.